ENTX

Entera Bio Ltd. Ordinary Shares (ENTX)

About Entera Bio Ltd. Ordinary Shares (ENTX)

Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH, GLP-E, and hGh, The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.

Details

Daily high

$2.21

Daily low

$2.08

Price at open

$2.16

52 Week High

$3.35

52 Week Low

$0.52

Market cap

77.3M

Dividend yield

0.00%

Volume

65,191

Avg. volume

55,813

P/E ratio

-8.07

Entera Bio Ltd. Ordinary Shares News